Last 12 months
Inside the activity.
9 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 9 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2022 Filed Aug 2, 2022 17:23 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000032 · wf-form4_165947542001598.xml · derivative · entry 2 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,036 Underlying: Common Stock · 757 shares Expires 2029-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:23 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 757 | $0.00 | $0.23 |
DisclosureSEC source: 0001779372-22-000032 · wf-form4_165947542001598.xml · nonDerivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2022 Filed Jul 20, 2022 01:32 UTC |
Ferrari RichardDirector
|
GrantCommon Stock | 73,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000030 · wf-form4_165828074027357.xml · nonDerivative · entry 1 Ferrari Richard · CIK 0001034413 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,529 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 15, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date. Read SEC document |
| July 15, 2022 Filed Jul 20, 2022 01:32 UTC |
Ortigas-Wedekind MargaDirector
|
GrantCommon Stock | 55,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000029 · wf-form4_165828071665697.xml · nonDerivative · entry 1 Ortigas-Wedekind Marga · CIK 0001453971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,147 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 15, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 21:33 UTC |
de Urioste GeorgeDirector
|
GrantCommon Stock | 55,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000031 · wf-form4_165828076227389.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,147 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 15, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date. Read SEC document |
| July 15, 2022 Filed Jul 20, 2022 01:31 UTC |
Elfrink WillemDirector
|
GrantCommon Stock | 55,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000028 · wf-form4_165828068652941.xml · nonDerivative · entry 1 Elfrink Willem · CIK 0001893194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,573 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 15, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 17:38 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionCommon Stock · Derivative | 757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000025 · wf-form4_165714349299147.xml · derivative · entry 2 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,793 Underlying: Common Stock · 757 shares Expires 2029-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 17:38 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 757 | $1.30 | $984.10 |
DisclosureSEC source: 0001779372-22-000025 · wf-form4_165714349299147.xml · nonDerivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 18:56 UTC Amendment |
Brounstein RichardChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000026 · wf-form4a_165714820140886.xml · derivative · entry 2 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,793 Underlying: Common Stock · 757 shares Expires 2029-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 18:56 UTC Amendment |
Brounstein RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 757 | $0.00 | $0.23 |
DisclosureSEC source: 0001779372-22-000026 · wf-form4a_165714820140886.xml · nonDerivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:15 UTC |
Elfrink WillemDirector
|
GrantWarrant (right to buy) · Derivative | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001779372-22-000024 · wf-form4_165584244236569.xml · derivative · entry 1 Elfrink Willem · CIK 0001893194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-11-11 F1 · derivative.exercise_price: The underlying warrant purchased by the reporting person represents the right to purchase one share of common stock of HeartBeam, Inc., at a purchase price of $6.00 per unit. The warrant is publicly trading on Nasdaq under the ticker symbol BEATW. F2 · price: Warrants purchased in multiple transactions on the same date at an average price of $0.56 per unit. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:59 UTC |
Vajdic BranislavChief Executive Officer
|
GrantStock option (right to buy) · Derivative | 359,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001779372-22-000020 · wf-form4_165550673218362.xml · derivative · entry 1 Vajdic Branislav · CIK 0001422425 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,000 Underlying: Common Stock · 359,000 shares Expires 2032-01-01 F1 · shares: The options ("Options") have been issued from the 2022 Executive Incentive Plan, that was approved at the Annual Shareholder Meeting held on June 15, 2022. F2 · derivative.exercise_date: The Option will vest and become exercisable with respect to 25% of the shares starting January 1, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date, such that 100% of the shares shall be fully vested and exercisable on January 1, 2027. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 18:59 UTC |
Brounstein RichardChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 80,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001779372-22-000022 · wf-form4_165550676791846.xml · derivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-01-01 F1 · shares: The options ("Options") have been issued from the 2022 Executive Incentive Plan, that was approved at the Annual Shareholder Meeting held on June 15, 2022. F2 · derivative.exercise_date: The Option will vest and become exercisable with respect to 25% of the shares starting January 1, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date, such that 100% of the shares shall be fully vested and exercisable on January 1, 2027. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 23:00 UTC |
Hunt Jon PatrickChief Business Officer
|
GrantStock option (right to buy) · Derivative | 72,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001779372-22-000023 · wf-form4_165550678511035.xml · derivative · entry 1 Hunt Jon Patrick · CIK 0001893665 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2032-06-15 F1 · shares: The options ("Options") have been issued from the 2022 Executive Incentive Plan, that was approved at the Annual Shareholder Meeting held on June 15, 2022. F2 · derivative.exercise_date: The Option will vest and become exercisable with respect to 25% of the shares starting June 15, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date, such that 100% of the shares shall be fully vested and exercisable on June 15, 2027. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:59 UTC |
Baumel AlanChief Operating Officer
|
GrantStock option (right to buy) · Derivative | 38,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001779372-22-000021 · wf-form4_165550675086939.xml · derivative · entry 1 Baumel Alan · CIK 0001900685 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2032-06-15 F1 · shares: The options ("Options") have been issued from the 2022 Executive Incentive Plan, that was approved at the Annual Shareholder Meeting held on June 15, 2022. F2 · derivative.exercise_date: The Option will vest and become exercisable with respect to 25% of the shares starting June 15, 2023 and one forty-eighth (1/48th) of the shares shall vest each calendar month thereafter on the same day of the month as the first vesting date, such that 100% of the shares shall be fully vested and exercisable on June 15, 2027. All Options shall accelerate and vest in full upon the Company's termination of the Reporting Person's engagement with the Company following a change in control. Read SEC document |
| June 02, 2022 Filed Jun 2, 2022 16:59 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000018 · wf-form4_165420355831048.xml · derivative · entry 2 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,550 Underlying: Common Stock · 757 shares Expires 2029-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2022 Filed Jun 2, 2022 16:59 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 757 | $0.00 | $0.23 |
DisclosureSEC source: 0001779372-22-000018 · wf-form4_165420355831048.xml · nonDerivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2022 Filed May 2, 2022 18:47 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000016 · wf-form4_165153161111534.xml · derivative · entry 2 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,307 Underlying: Common Stock · 757 shares Expires 2029-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2022 Filed May 2, 2022 18:47 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 757 | $0.00 | $0.23 |
DisclosureSEC source: 0001779372-22-000016 · wf-form4_165153161111534.xml · nonDerivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2022 Filed Apr 4, 2022 16:42 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000013 · wf-form4_164910490792571.xml · derivative · entry 2 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,064 Underlying: Common Stock · 757 shares Expires 2029-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2022 Filed Apr 4, 2022 16:42 UTC |
Brounstein RichardChief Financial Officer
|
GrantCommon Stock | 757 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000013 · wf-form4_164910490792571.xml · nonDerivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,860 Read SEC document |
| March 30, 2022 Filed Apr 4, 2022 16:42 UTC |
Brounstein RichardChief Financial Officer
|
PurchaseWarrant (right to buy) · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000013 · wf-form4_164910490792571.xml · derivative · entry 3 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-11-11 F1 · derivative.exercise_price: The underlying warrant purchased by the reporting person represents the right to purchase one share of common stock of HeartBeam, Inc., at a purchase price of $6.00 per unit. The warrant is publicly trading on Nasdaq under the ticker symbol BEATW. F2 · price: Warrant purchase price $0.35 per unit. Read SEC document |
| March 29, 2022 Filed Apr 1, 2022 01:25 UTC |
Vajdic BranislavChief Executive Officer
|
PurchaseWarrant (right to buy) · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000012 · wf-form4_164877628905987.xml · derivative · entry 1 Vajdic Branislav · CIK 0001422425 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 10,000 shares Expires 2026-11-11 F1 · derivative.exercise_price: The underlying warrant purchased by the reporting person represents the right to purchase one share of common stock of HeartBeam, Inc., at a purchase price of $6.00 per unit. The warrant is publicly trading on Nasdaq under the ticker symbol BEATW. F2 · price: Warrant purchase price $0.35 per unit. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 16:16 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000008 · wf-form4_164634216969314.xml · derivative · entry 2 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,821 Underlying: Common Stock · 757 shares Expires 2029-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 16:16 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 757 | $0.00 | $0.23 |
DisclosureSEC source: 0001779372-22-000008 · wf-form4_164634216969314.xml · nonDerivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 3, 2022 16:14 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000006 · wf-form4_164392285088357.xml · derivative · entry 2 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,578 Underlying: Common Stock · 757 shares Expires 2029-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 3, 2022 16:14 UTC |
Brounstein RichardChief Financial Officer
|
GrantCommon Stock | 757 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000006 · wf-form4_164392285088357.xml · nonDerivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,346 Read SEC document |
| January 02, 2022 Filed Jan 3, 2022 19:20 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 1,514 | $0.00 Strike: $0.00 | $0.45 |
DisclosureSEC source: 0001779372-22-000001 · wf-form4_164125563049298.xml · derivative · entry 2 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,335 Underlying: Common Stock · 1,514 shares Expires 2029-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2022 Filed Jan 3, 2022 19:20 UTC |
Brounstein RichardChief Financial Officer
|
Exercise / conversionCommon Stock | 1,514 | $0.00 | $0.45 |
DisclosureSEC source: 0001779372-22-000001 · wf-form4_164125563049298.xml · nonDerivative · entry 1 Brounstein Richard · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 00:21 UTC |
Vajdic BranislavChief Executive Officer
|
PurchaseWarrant (right to buy) · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000002 · wf-form4_164125564773275.xml · derivative · entry 1 Vajdic Branislav · CIK 0001422425 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-11-11 F1 · derivative.exercise_price: The underlying warrant purchased by the reporting person represents the right to purchase one share of common stock of HeartBeam, Inc Read SEC document |
| December 30, 2021 Filed Jan 6, 2022 21:20 UTC Amendment |
Vajdic BranislavChief Executive Officer
|
PurchaseWarrant (right to buy) · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000003 · wf-form4a_164150403695996.xml · derivative · entry 1 Vajdic Branislav · CIK 0001422425 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-11-11 F1 · derivative.exercise_price: The underlying warrant purchased by the reporting person represents the right to purchase one share of common stock of HeartBeam, Inc., at a purchase price of $6.00 per unit. The warrant is publicly trading on Nasdaq under the ticker symbol BEATW. F2 · price: Warrant purchase price $0.84-$0.85 per unit. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 17:59 UTC |
Brounstein RichardChief Financial Officer
|
PurchaseCommon Stock | 5,000 | $3.37 | $16,846.00 |
DisclosureSEC source: 0001779372-21-000004 · wf-form4_164030036875577.xml · nonDerivative · entry 1 BROUNSTEIN RICHARD D · CIK 0001189694 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,075 Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 23:00 UTC |
Elfrink WillemDirector
|
PurchaseWarrant (right to buy) · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-21-000005 · wf-form4_164030038690390.xml · derivative · entry 1 Elfrink Willhem · CIK 0001893194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-11-11 F1 · derivative.exercise_price: The underlying warrant purchased by the reporting person represents the right to purchase one share of common stock of HeartBeam, Inc Read SEC document |
| December 21, 2021 Filed Jan 6, 2022 21:21 UTC Amendment |
Elfrink WillemDirector
|
GrantWarrant (right to buy) · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001779372-22-000004 · wf-form4a_164150405865625.xml · derivative · entry 1 Elfrink Willem · CIK 0001893194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-11-11 F1 · derivative.exercise_price: The underlying warrant purchased by the reporting person represents the right to purchase one share of common stock of HeartBeam, Inc., at a purchase price of $6.00 per unit. The warrant is publicly trading on Nasdaq under the ticker symbol BEATW. F2 · price: Warrant purchase price $0.88-$0.89 per unit. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:57 UTC |
de Urioste GeorgeDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001213900-21-059710 · ownership.xml · derivative · entry 1 DE URIOSTE GEORGE · CIK 0001270068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2031-07-25 F1 · derivative.exercise_date: The option will vest one forty-eighth of the shares on each one-month anniversary of the vesting commencement date such that 100% of the shares subject to the option will be fully vested and exercisable on August 27, 2025. F2 · derivative.exercise_date: All shares subject to the option shall accelerate and vest in full upon the Company's termination of the optionee's engagement with the Company following a Change in Control (as defined in the agreement). Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 11:16 UTC |
Hunt Jon PatrickChief Business Officer
|
GrantCommon Stock Option (right to buy) · Derivative | 87,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001213900-21-059742 · ownership.xml · derivative · entry 2 Hunt Jon Patrick · CIK 0001893665 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,000 Underlying: Common Stock · 87,000 shares Expires 2031-09-15 F3 · derivative.exercise_date: The option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the vesting commencement date September 15, 2021 and one forty-eighth (1/48th) of the shares subject to the option shall vest each calendar month thereafter on the same day of the month as the vesting commencement date, such that 100% of the shares subject to the option will be fully vested and exercisable on August 15, 2025. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 02:58 UTC |
Ferrari RichardDirector
|
Exercise / conversionCommon Stock | 65,653 | $4.20 | $275,742.60 |
DisclosureSEC source: 0001213900-21-059714 · ownership.xml · nonDerivative · entry 1 FERRARI RICHARD M · CIK 0001034413 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 65,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares purchased from conversion of convertible note, principal and interest of $275,743. F2 · ownership.nature: The underlying common stock is held by the Ferrari Living Trust, of which the Reporting Person is the trustee. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 02:59 UTC |
Ortigas-Wedekind MargaDirector
|
GrantWarrant (right to buy) · Derivative | 9,000 | $6.00 | $54,000.00 |
DisclosureSEC source: 0001213900-21-059715 · ownership.xml · derivative · entry 3 Ortigas-Wedekind Marga · CIK 0001453971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2026-11-11 F3 · derivative.exercise_price: The underlying warrant granted to the reporting person represents the right to purchase one share of common stock of HeartBeam, Inc. F4 · ownership.nature: The underlying warrant is held by the Wedekind Living Trust, of which the Reporting Person is the trustee. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 02:59 UTC |
Ortigas-Wedekind MargaDirector
|
PurchaseCommon Stock | 9,000 | $5.99 | $53,910.00 |
DisclosureSEC source: 0001213900-21-059715 · ownership.xml · nonDerivative · entry 2 Ortigas-Wedekind Marga · CIK 0001453971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,824 F2 · ownership.nature: The underlying common stock is held by the Wedekind Living Trust, of which the Reporting Person is the trustee. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 02:59 UTC |
Ortigas-Wedekind MargaDirector
|
Exercise / conversionCommon Stock | 7,824 | $4.20 | $32,860.80 |
DisclosureSEC source: 0001213900-21-059715 · ownership.xml · nonDerivative · entry 1 Ortigas-Wedekind Marga · CIK 0001453971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares purchased from conversion of convertible note, principal and interest of $32,861. F2 · ownership.nature: The underlying common stock is held by the Wedekind Living Trust, of which the Reporting Person is the trustee. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:00 UTC |
Brounstein RichardCHIEF FINANCIAL OFFICER
|
GrantWarrant (right to buy) · Derivative | 5,000 | $6.00 | $30,000.00 |
DisclosureSEC source: 0001213900-21-059716 · ownership.xml · derivative · entry 4 BROUNSTEIN RICHARD D · CIK 0001189694 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-11-11 F5 · derivative.exercise_price: The underlying warrant granted to the reporting person represents the right to purchase one share of common stock of HeartBeam, Inc. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:00 UTC |
Brounstein RichardCHIEF FINANCIAL OFFICER
|
PurchaseCommon Stock | 5,000 | $5.99 | $29,950.00 |
DisclosureSEC source: 0001213900-21-059716 · ownership.xml · nonDerivative · entry 3 BROUNSTEIN RICHARD D · CIK 0001189694 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,075 Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:00 UTC |
Brounstein RichardCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 9,732 | $4.20 | $40,874.40 |
DisclosureSEC source: 0001213900-21-059716 · ownership.xml · nonDerivative · entry 2 BROUNSTEIN RICHARD D · CIK 0001189694 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 92,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares purchased from conversion of convertible note, principal and interest of $40,874. F4 · ownership.nature: The underlying common stock is held by CTRLCFO, LLC, of which the Reporting Person is the Manager. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:00 UTC |
Brounstein RichardCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 19,465 | $4.20 | $81,753.00 |
DisclosureSEC source: 0001213900-21-059716 · ownership.xml · nonDerivative · entry 1 BROUNSTEIN RICHARD D · CIK 0001189694 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 82,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares purchased from conversion of convertible note, principal and interest of $81,753. F2 · ownership.nature: The underlying common stock is held by the R and S Brounstein Living Trust, of which the Reporting Person is a Trustee. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 02:57 UTC |
Elfrink WillemDirector
|
Exercise / conversionCommon Stock | 164,610 | $4.20 | $691,362.00 |
DisclosureSEC source: 0001213900-21-059711 · ownership.xml · nonDerivative · entry 3 Elfrink Willhem · CIK 0001893194 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 437,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares purchased from conversion of convertible note, principal and interest of $691,362. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 02:57 UTC |
Elfrink WillemDirector
|
Exercise / conversionCommon Stock | 106,825 | $4.20 | $448,665.00 |
DisclosureSEC source: 0001213900-21-059711 · ownership.xml · nonDerivative · entry 2 Elfrink Willhem · CIK 0001893194 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 273,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares purchased from conversion of convertible note, principal and interest of $448,665. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 02:57 UTC |
Elfrink WillemDirector
|
Exercise / conversionCommon Stock | 60,972 | $4.20 | $256,082.40 |
DisclosureSEC source: 0001213900-21-059711 · ownership.xml · nonDerivative · entry 1 Elfrink Willhem · CIK 0001893194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares purchased from conversion of convertible note, principal and interest of $256,082. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 11:19 UTC |
Vajdic BranislavCHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 115,559 | $4.20 | $485,347.80 |
DisclosureSEC source: 0001213900-21-059746 · ownership.xml · nonDerivative · entry 1 Vajdic Branislav · CIK 0001422425 · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares purchased from conversion of convertible note, principal and interest of $485,348. Read SEC document |
| November 11, 2021 Filed Nov 16, 2021 11:16 UTC |
Hunt Jon PatrickChief Business Officer
|
Exercise / conversionCommon Stock | 23,976 | $4.20 | $100,699.20 |
DisclosureSEC source: 0001213900-21-059742 · ownership.xml · nonDerivative · entry 1 Hunt Jon Patrick · CIK 0001893665 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 23,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares purchased from conversion of convertible note, principal and interest of $100,699. F2 · ownership.nature: The underlying common stock is held by Jon P and Christine M Hunt. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.